An international trial is likely to involve many more collaborators than a UK-based trial and will depend upon their continued support and collaboration for the successful delivery of the trial.

Given the contributions of so many stakeholders, which should be recognised, it is important that the authorship and publication policy is agreed early in the trial set-up stage.

There are two main authorship models:

  1. Collaborative/corporate authorship.

    Within the corporate authorship model, publications are attributed to the collaborative group. Recent publications of surgery trials using this model include the FOxTROT Pilot Trial (1) and the DREAMS Trial (2).

    1. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. The FOxTROT Collaborative Group, Lancet Oncol. 2012; 13:1152-60.
    2. Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial). DREAMS Trial Collaborative and the West Midlands Research Collaborative. BMJ 2017; 357:1455.

  2. Named authorship.

    A publication using the named authorship model lists the names and affiliations of the writing group in the paper byline.

<span style='color:#dddddd; font-size:24px;' class='wp-svg-link link'></span> Links